Suppr超能文献

采用骨内或静脉输注高渗盐右旋糖酐溶液治疗失血性休克。

Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution.

作者信息

Chávez-Negrete A, Majluf Cruz S, Frati Munari A, Perches A, Argüero R

机构信息

Department of Internal Medicine, La Raza Medical Center, IMSS, Mexico City, Mexico.

出版信息

Eur Surg Res. 1991;23(2):123-9. doi: 10.1159/000129144.

Abstract

The efficacy of intravenous or intraosseous infusion of 250 ml of 7.5% NaCl and 6% dextran 60 (H/H) was compared with intravenous Ringer's lactate (RL) for the initial treatment of patients with hemorrhagic shock due to upper gastrointestinal bleeding. 49 patients were randomly assigned to receive either H/H (n = 26) or RL (n = 23). In the first 16 patients with H/H and in all RL patients, solutions were infused by the intravenous route, while the intraosseous route through sternal puncture was chosen for the last 10 H/H subjects. H/H patients were analyzed together since no differences were noticed between the routes of infusion. The H/H group also received 2.3 +/- 0.7 liters of intravenous crystalloid solutions in the first hour and 4.4 +/- 0.1 liters in the 24-hour period, while RL received 3.3 +/- 0.7 and 7.3 +/- 2.4 liters, respectively. Blood pressure (BP) increased during the first 15 min in the H/H group (from 61 +/- 17/30 +/- 12 to 85 +/- 30/48 +/- 14 mm Hg) and thereafter, while remaining unchanged in the RL group (from 75 +/- 18/40 +/- 12 to 75 +/- 17/40 +/- 14 mm Hg; p less than 0.05). The differences between groups were significant throughout 24 h. Urine output and improvement of the Glasgow Coma Score were also higher in H/H patients than in the control group (p less than 0.05). There were 5 deaths in RL group and 1 in the H/H group. Sternal of peripheral vein infusion of 250 ml of 7.5% NaCl/6% dextran 60 is an effective initial treatment of hemorrhagic shock.

摘要

将250毫升7.5%氯化钠和6%右旋糖酐60(H/H)静脉输注或骨内输注的疗效与静脉输注乳酸林格液(RL)用于上消化道出血所致失血性休克患者的初始治疗进行比较。49例患者被随机分配接受H/H(n = 26)或RL(n = 23)治疗。在最初的16例接受H/H治疗的患者以及所有接受RL治疗的患者中,溶液通过静脉途径输注,而最后10例接受H/H治疗的患者则选择通过胸骨穿刺的骨内途径。由于在输注途径之间未发现差异,因此对H/H患者进行了综合分析。H/H组在第1小时还接受了2.3±0.7升静脉晶体溶液,在24小时内接受了4.4±0.1升,而RL组分别接受了3.3±0.7升和7.3±2.4升。H/H组在最初15分钟内血压(BP)升高(从61±17/30±12毫米汞柱升至85±30/48±14毫米汞柱),此后保持升高,而RL组血压保持不变(从75±18/40±12毫米汞柱升至75±17/40±14毫米汞柱;p<0.05)。两组之间的差异在24小时内均具有显著性。H/H患者的尿量和格拉斯哥昏迷评分的改善也高于对照组(p<0.05)。RL组有5例死亡,H/H组有1例死亡。胸骨或外周静脉输注250毫升7.5%氯化钠/6%右旋糖酐60是失血性休克有效的初始治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验